Conditions: Myocardial Infarction Cardiovascular Death Atherothrombosis Stroke
Keywords: Heart attack Heart Disease Acute coronary syndrome ACS Cardiovascular Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 21379
Healthy volunteers: no

Brief summary:
This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke).

Detailed description:

Arms:
arm 1: Oral Treatment arm 2: Oral Treatment arm 3: Oral Treatment

Interventions: intervention 1: Ticagrelor 90 mg intervention 2: Ticagrelor 60 mg intervention 3: Ticagrelor Placebo
Intervention descriptions: intervention 1: Oral dose twice a day intervention 2: Oral dose twice a day intervention 3: Oral dose twice a day

Protocol document: